Unigen, Inc.
Regan Miles has extensive experience in the health and wellness industry. Regan has held various leadership roles throughout their career. Regan served as the President and CEO of Unigen, Inc. from March 2015 to July 2021 and then returned to the company as President and CEO in June 2023. Prior to that, they worked as the Vice Chairman of Unigen, Inc. from August 2021 to June 2023. Before joining Unigen, Inc., Regan was the President of Next Pharmaceuticals from May 2011 to February 2015. Regan also served as the CEO of Univera, Inc. from August 2007 to November 2010. Earlier in their career, they held executive positions at other companies such as Unigen, Inc., Integrative Therapeutics, Alpine Health Industries, Pharmanex, and Nature's Way.
Regan Miles attended Brigham Young University from 1980 to 1984, studying Business Management.
This person is not in any teams
Unigen, Inc.
1 followers
From discovery to distribution, Unigen is dedicated to the development of botanical and marine-derived therapeutic compounds that address consumer health needs and improve quality of life. Established in 1996, our research and discovery process includes extensive testing at the genetic, cellular, and human clinical levels. Unigen is a global leader in the discovery and development of proprietary natural ingredients for the dietary supplement, food, cosmetics, personal care and pharmaceutical industries. With a core of scientifically substantiated natural ingredients already distribute worldwide, we continue to push the boundaries of pharmaceutical quality research and novel applications for natural products. The company has one of the most extensive medicinal plant collections in the world and utilizes a state-of-the-art pharmaceutical discovery approach to identify the most safe and effective botanically-based proprietary ingredients. The efficacy of Unigen’s natural product ingredients is established through human clinical trials, and unlike synthetic drugs, Unigen’s natural substances have a legacy of safe human consumption without the undesirable side-effects that limit the use of pharmaceuticals. Unigen protects its discoveries through patents and commercializes its products through alliances with partners that possess distribution and marketing capabilities in each of Unigen’s target markets.